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A protein factor that specifically binds to the 5’untranslated region of encephfomyocarditis virus (EMCV) RNA has been found in extracts of 
ascites carcinoma Krebs-2 cells. This was done using UV-irradiation on extracts supplemented with in vitro synthesized s2P-lab&d transcripts 
followed by analysis of crosslinked proteins by SDS-polyacrylamide gel electropboresis. The transcripts represented the viral RNA sequence from 
nt 31.5 to 1155, its derivatives with internal deletions or truncated forms. This set of transcripts has allowed us to Bnd out hat the factor (p58) 
binds to EMCV RNA within the sequence 315-485. 
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1. INTR~~U~IUN 
Encephalomyocarditis virus RNA as well as RNAs of 
other picornaviruses are of current interest due to a 
puzzling mechanism which they use to initiate transla- 
tion [l-4]. Some RNA properties are not in agreement 
with Kozak’s scanning model of eucaryotic translation 
initiation j6,?]. It can be explained by suggesting that 
EMCV RNA is capable of the internal initiation of 
translation, i.e. independent of the 5 ‘-end entry of the 
ribosome into the mRNA initiation site. It has recently 
been proven not only for EMC [5f, but also for 
poliovirus 19. It is plausible to suggest that there are 
some special trans-acting cellular factors which trigger 
the internal initiation. 
polymerase reaction iaxor&ng to [S] with slight modifications. 
Specific activity of r~-32P]UTP-~a~Iied (3000 WmmoI) transcripts 
was about Id cpm/yg RNA. 
T7 polymerase was prepared from the superproducing strain of E. 
coii (containing PAR 1219) kindly provided by K. Langereis (Leiden) 
according to [12] with some modifications. The preparation of 
Krebs-2 cell extracts, microsomal fraction and ribosomal high salt 
wash was carried out as in 113-151, respectively. 
Using various in vitro synthesized erivatives of the 
leader region of EMCV RNA, we have shown by the 
method of UV-crosslinking that ascites carcinoma 
Krebs-2 cells do contain a protein with an M, about 
58000 which recognizes the 5’-UTR within the se- 
quence 315-485 of EMCV RNA. 
Crosslinking experiments were performed as in 1131 with 254 nm 
light (an incidental dose of 2 x 10’ erg/mm’). Samples (25 $1 with 
composition, optimized for transiation of EMCV RNA in vitro, were 
incubate for 5 rnin at 30°C before irradiation IS]. They contained 
1.5 ~1 of the extracts and Id cpm of a s2F-1abeRed transcript. After 
irradiation the samples were treated for X3 min at 37°C with cobra 
venom ribonuclease (Minor Bio, Estonia) witb a final concentration 
0.2 .ug/~l, and then with a mixture of ribonucleases A (0.4 pg/& and 
Ti (5 U/yl) for 30 min at 37°C with addition of EDTA to a 10 mM 
concentration. Cross-linked proteins were analyzed by elec- 
trophoresis in a gradient PAAG (l&20%) containing SDS [14]. 
3. RESULTS 
2. MATERIALS AND METIIODS 
The construction of the starting ptasmid pTEl as well as of its trun- 
cated and deleted erivatives is described elsewhere [9]. pT7-2-42 con- 
taming a DNA copy of AlMV RNA 4 under control of TFpromotor 
[lO] was kindly provided by K. Lange& (Leiden). The plasmids 
linearized with suitable restriction endonucleases were used in T7 
Correspondence addrw: I.N. Shatsky, A.N. Belozersky Laboratory, 
Moscow State University, Leninsky Hihs, t19899 Moscow, USSR 
The initial construction, pTE1 I contains a part of the 
5 ’ -UTR of EMCV genome from 3 15 to 833 nt and a se- 
quence encoding the 5’-terminal fragment of the 
polyprotein (up to 1155 at; fig.1). As we have recently 
shown, the correspond~g transcript has a very high 
translational activity in vitro and hence, contains all the 
necessary signals for the initiation process 191. The 
same construction through linearization at its cor- 
responding restriction sites, Hind111 and B&I, was used 
to obtain transcripts truncated from the 3 ‘-end, tr 
315-485 and tr 315-837, respectively. 
Abbreviations: EMCV, encephalomyocarditis virus; AIMV, alfalfa 
mosaic virus; 5 ‘-UTR, 5’-untranslated region; tr, transcript; nt, 
nucleotide; FAAG, ~~~~~~de gel 
The transcripts synthesized on other plasmids repre- 
sent either truncated from the 5 ‘-end derivatives of 
pTE1 or contain deletions in different sites of the 
5’-UTR (fig.1). Their tr~slation~ activity has been 
recently analyzed by us in Krebs-2 cell extracts [9]. 
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Fig. 1. Constructions used to obtain truncated from the 5 ‘-end derivatives of the 5 ’ -UTR of EMCV RNA (A) or its deleted forms (B). T7 promotor 
is shown by hatched boxes. 
Almost all of them proved to be completely inactive. 
However, in the case of tr 485, some residual activity 
in the cap-independent initiation still remained. This set 
of RNAs was supposed to be a convenient ool to look 
for factors recognizing the 5 ‘-UTR of EMCV RNA. 
-67kD 
-43 kD 
Fig.2. Autoradiographs showing proteins from extracts of ascites 
carcinoma Krebs-2 cells crosslinked to different derivatives of the 
5’-UTR of EMCV RNA. (1) tr 315-837; (2) tr 485; (3) tr 647; (4) 
anti-tr 3 15. Arrows indicate positions of marker proteins. Patterns of 
proteins crosslinked to tr 563 and tr 767 are similar to that for tr 485 
and not shown in the figure. 
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Also, as a control, in vitro synthesized AlMV RNA4 
and antisense RNA complementary to tr 315 have been 
used. 
Ascite cell extracts have been supplemented with the 
“P-1abelled transcripts, UV-irradiated, treated with 
RNases and then analyzed by electrophoresis in PAAG. 
As seen in fig.2, most of the radioactive bands are iden- 
tical for all transcripts mentioned above. Treatment of 
the samples with proteinase K, proved these bands to be 
not unhydrolyzed RNA fragments, but UV-crosslinked 
proteins (data not shown). 
However, apart from the proteins common to all 
RNAs an additional broad band with A4, in the range 
of 50000-60000 is revealed for EMCV tr 315-837. 
-67kD 
-43kD 
Fig.3. Proteins from extracts of ascites cells UV-crosslinked to: (1) tr 
315-837; (2) tr 315-485; (3) tr 315(6701-763); (4) tr 
315-701(6488-647). 
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This band is absent in the case of antisense RNA, trs 
485,563,647 and 763 and hardly seen for AlMV RNA4 
(fig.2A). The EMCV RNAs with deleted nt 701-763 
and 488-647 retain the ability to bind this protein(s) 
(fig.3). This raised the possibility that the recognition 
site of the factor(s) is located somewhere between posi- 
tions 315 and 485 of EMCV RNA. Indeed, the ex- 
periments with tr 315-485 (fig.3, lane 2) have 
confirmed this suggestion. 
At a lower exposure of the gels, the broad band of 
the crosslinked products specific for the EMCV 
5 ’ -UTR is often revealed as a quadruplet, Preliminary 
experiments with the use of mobi~ty-shift elec- 
trophoresis 1181 seem to indicate that it is accounted for 
by incomplete digestion of oligonucleotides crosslinked 
to a single protein with Mt about 58000 (hereafter 
referred to as ~58) rather than by a set of different pro- 
tein factors (our unpub~shed observations). The ex- 
tracts with lower ionic strength reveal an additional 
crosslinked protein with a similar MI for all the 
transcripts including antisense-tr 315 (see some ex- 
amples in fig.4). Its relation to ~58 is unclear. At any 
rate, under all conditions the intensity of the respective 
band for transcripts encompassing nt 315-485 of 
EMCV RNA is much stronger than for all other RNAs. 
pS8 is unlikely to be ATP- or ~TP-dependent protein 
since the presence or absence of these nucleotides in ex- 
tracts does not affect its crosslinking to the 
EMCV RNA (data not shown). 
123456789 
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Fig.4. Proteins crosslinked to different derivatives of the 5’-UTR of 
EMCV RNA at 50 mM K (lanes 1, 3, 5, 6 and 8) and 170 mM K+ 
(lanes 2, 4, 7 and 9). (1,2) tr 563-763; (3,4) tr 315(6488-647); (5) tr 
647; (6,7) tr 563; (8,9) anti-n 315. 
12345 678 
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Fig.5 Proteins from a ribosomal high salt wash cross~nked to 
deleted derivatives of tr 3 15. (I,3 and 6) 25-40% ammonium sulfate 
fraction of the ribosomal high salt wash; (2,4 and 7) 40-70% 
fraction; (5,s) unfractionated factors. (1,2) tr 315(0701-763); (3,4 
and 5) tr 315(A488-647); (6,7 and 8) AlMV RNA-4. The samples 
(25 ~1) contained 2.5 AZW units of 2540% fraction or I .8 Aass units 
of 40-70% fraction or both. 
Subcellular distribution of ~58 has not been deter- 
mined in this work. Nevertheless it is clear that ~58 is 
present in a ribosomal high salt wash, particularly in 
~rno~urn sulphate 25-40% saturation fraction 
(fig.5). 
It is of interest hat on removal of some proteins, in- 
cluding ~58 from unfra~tionated ribosome-bound fac- 
tors, new proteins can be efficiently crosslinked to 
some derivatives of the 5’-UTR of EMCV RNA (fig.5, 
lanes 3-5). This suggests a competition between some 
cellular factors for the same sequences in the leader of 
EMCV RNA. 
4. DISCUSSION 
The results obtained strongly suggest that scites car- 
cinoma Krebs-2 cells contain a protein factor (~58) 
which specifically binds to the 5 ’ -UTR of EMCV 
RNA. The recognition sequence locates between nt 315 
and 485 of the viral genome. It is important o note that 
the factor crosslinks equally well to tr 3 15-485 alone or 
when it is a part of a longer sequence (tr 315 or tr 
315-837). In the latter case, the 3’-terminal part of the 
315-485 sequence which is thought to be functionally 
important for translation 1191 must be incorporated, 
according to Pilipenko et al. 1201, into a long helix of 
the 5’-UTR (domain III). Then it appears that the 
disruption of the lower part of the helix does not 
abolish the recognition site. Further experiments will 
clarify whether the ~58 recognition site is located in the 
5’-part, or in the 3’-part of 315-485 fragment. 
239 
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Rabbit reticulocyte extracts either do not contain ~58 
or its concentration in these cells is much lower than in 
ascite cells. Furthermore, on fractionation of the crude 
KC1 wash from ascites cells, ~58 does not co-elute with 
any of the known translational factors (our unpublish- 
ed data). These observations argue against he possibili- 
ty that p58 represents one of the main initiation factors 
common to all mammalian cells. 
At present, we have no evidence that p58 is indeed a 
cellular trans-factor that confers the cap-independent 
initiation of translation of EMCV RNA. Moreover, a 
high efficiency of translation of EMCV RNA in rabbit 
reticulocyte extract [21] seems to argue against this 
possibility. However, it is not unlikely that either small 
amounts of ~58 in reticulocytes are sufficient for 
EMCV RNA translation initiation or that another pro- 
tein(s) is responsible for similar triggering function in 
these extracts. 
Apparently, ~58 and its corresponding recognition 
site cannot determine entirely the internal initiation 
within the 5 ’ -UTR of EMCV RNA. Indeed, even a 
small deletion in the 5 ’ -UTR, far downstream from nt 
485 (A707-723), completely abolishes the activity of 
the leader of EMCV RNA in the initiation of transla- 
tion [9]. 
Recently, N. Sonenberg et al. [22] have found a pro- 
tein factor ~52 specific for poliovirus RNA which ap- 
pears to be involved in the internal initiation of 
translation in HeLa cells. The relation of ~52 to ~58 is 
unclear. The role of p58 in expression of both EMCV 
RNA and probably some cellular RNAs will be the aim 
of further experiments. 
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